Table 6.
Summary of the Evidence Supporting Peroral Endoscopic Myotomy in Patients With Type III Achalasia
Study | Country | Study design | Participants | Intervention | Comparator | Follow-up duration | Outcome |
---|---|---|---|---|---|---|---|
2015, Kumbhari et al92 | International (4 USA, 3 Asian, and 1 European centers) | Retrospective cohort study | Type 3 achalasia patients who underwent POEM or LHM | POEM, n = 49 | LHM, n = 26 | POEM, mean 8.6 mo; LHM, mean 21.5 mo | Median procedure time, min: POEM, 102 (43-345); LHM, 264 (189-331)Clinical response rate: POEM, 98.0% (n = 48); LHM, 80.8% (n = 21) |
2017, Khan et al95 | USA | Meta-analysis | Eight studies on type 3 achalasia patients who underwent POEM | POEM, n = 179 | None | Range, 3 mo-3 yr | Clinical success rate (8 studies): 91.6% (95% CI, 84.3-95.7%)Adverse event rate (8 studies): 11.2% (95% CI, 6.3-19.0%) |
POEM, peroral endoscopic myotomy; LHM, laparoscopic Heller myotomy; CI, confidence interval.